|
Name |
2-Methyl-1,2,3,4-tetrahydronaphthalen-1-ol
|
Molecular Formula | C11H14O | |
IUPAC Name* |
2-methyl-1,2,3,4-tetrahydronaphthalen-1-ol
|
|
SMILES |
CC1CCC2=CC=CC=C2C1O
|
|
InChI |
InChI=1S/C11H14O/c1-8-6-7-9-4-2-3-5-10(9)11(8)12/h2-5,8,11-12H,6-7H2,1H3
|
|
InChIKey |
UMUJQRABWPODKX-UHFFFAOYSA-N
|
|
Synonyms |
2-methyl-1,2,3,4-tetrahydronaphthalen-1-ol; 32281-70-2; 1,2,3,4-Tetrahydro-2-methyl-1-naphthol; 1,2,3,4-tetrahydro-2-methylnaphthalen-1-ol; 1-Naphthol, 1,2,3,4-tetrahydro-2-methyl-; SCHEMBL2190921; AMY6134; DTXSID301268559; ZB1755; AKOS011021388; DB-102864; CS-0068753; 1,2,3,4-Tetrahydro-2-methyl-1-naphthalenol; 2-Methyl-1,2,3,4-tetrahydro-1-naphthalenol #
|
|
CAS | 32281-70-2 | |
PubChem CID | 577664 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 162.23 | ALogp: | 2.3 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 0 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 2 |
Heavy Atoms: | 12 | QED Weighted: | 0.621 |
Caco-2 Permeability: | -4.377 | MDCK Permeability: | 0.00002600 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.032 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.627 |
30% Bioavailability (F30%): | 0.036 |
Blood-Brain-Barrier Penetration (BBB): | 0.919 | Plasma Protein Binding (PPB): | 84.23% |
Volume Distribution (VD): | 1.576 | Fu: | 14.88% |
CYP1A2-inhibitor: | 0.333 | CYP1A2-substrate: | 0.898 |
CYP2C19-inhibitor: | 0.176 | CYP2C19-substrate: | 0.761 |
CYP2C9-inhibitor: | 0.051 | CYP2C9-substrate: | 0.807 |
CYP2D6-inhibitor: | 0.013 | CYP2D6-substrate: | 0.887 |
CYP3A4-inhibitor: | 0.013 | CYP3A4-substrate: | 0.52 |
Clearance (CL): | 8.53 | Half-life (T1/2): | 0.414 |
hERG Blockers: | 0.029 | Human Hepatotoxicity (H-HT): | 0.084 |
Drug-inuced Liver Injury (DILI): | 0.042 | AMES Toxicity: | 0.247 |
Rat Oral Acute Toxicity: | 0.102 | Maximum Recommended Daily Dose: | 0.095 |
Skin Sensitization: | 0.177 | Carcinogencity: | 0.184 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.498 |
Respiratory Toxicity: | 0.063 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC006142 | 0.447 | D06OMW | 0.469 | ||||
ENC004793 | 0.447 | D05IHU | 0.386 | ||||
ENC002250 | 0.435 | D0R8PX | 0.364 | ||||
ENC000345 | 0.386 | D0MP5H | 0.315 | ||||
ENC001031 | 0.383 | D0M2MC | 0.309 | ||||
ENC000917 | 0.378 | D0T6SU | 0.298 | ||||
ENC005244 | 0.360 | D0L9ZR | 0.295 | ||||
ENC000038 | 0.347 | D04QZD | 0.294 | ||||
ENC006050 | 0.346 | D0H0HJ | 0.292 | ||||
ENC000028 | 0.333 | D01JMC | 0.291 |